D. E. Shaw & Co., Inc. Lexicon Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.0 - $1.53 $424,912 - $650,115	-424,912 Reduced 54.19%	359,210 $549,000
Q3 2023 Nov 14, 2023	SELL	$1.06 - $2.33 $455,380 - $1 Million	-429,604 Reduced 35.4%	784,122 $854,000
Q2 2023 Aug 14, 2023	SELL	$2.15 - $3.49 $3.71 Million - $6.03 Million	-1,727,271 Reduced 58.73%	1,213,726 $2.78 Million
Q1 2023 May 15, 2023	SELL	$1.99 - $2.68 $272,582 - $367,095	-136,976 Reduced 4.45%	2,940,997 $7.15 Million
Q4 2022 Feb 14, 2023	BUY	$1.8 - $2.56 $61,192 - $87,029	33,996 Added 1.12%	3,077,973 $5.88 Million
Q3 2022 Nov 14, 2022	SELL	$1.94 - $3.43 $357,144 - $631,445	-184,095 Reduced 5.7%	3,043,977 $7.31 Million
Q2 2022 Aug 15, 2022	SELL	$1.31 - $2.69 $827 - $1,700	-632 Reduced 0.02%	3,228,072 $6 Million
Q1 2022 May 16, 2022	BUY	$1.95 - $3.89 $819,538 - $1.63 Million	420,276 Added 14.96%	3,228,704 $6.75 Million
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.16 $1.55 Million - $2.51 Million	-407,620 Reduced 12.67%	2,808,428 $11.1 Million
Q3 2021 Nov 15, 2021	SELL	$3.38 - $5.35 $629,954 - $997,116	-186,377 Reduced 5.48%	3,216,048 $15.5 Million
Q2 2021 Aug 16, 2021	BUY	$4.12 - $5.87 $1.63 Million - $2.32 Million	395,813 Added 13.16%	3,402,425 $15.6 Million
Q1 2021 May 17, 2021	BUY	$3.45 - $9.09 $4.18 Million - $11 Million	1,212,603 Added 67.59%	3,006,612 $17.6 Million
Q4 2020 Feb 16, 2021	BUY	$1.05 - $3.67 $868,772 - $3.04 Million	827,402 Added 85.6%	1,794,009 $6.14 Million
Q3 2020 Nov 16, 2020	SELL	$1.44 - $2.1 $507,663 - $740,342	-352,544 Reduced 26.73%	966,607 $1.39 Million
Q2 2020 Aug 14, 2020	BUY	$1.75 - $2.3 $1.41 Million - $1.86 Million	806,739 Added 157.44%	1,319,151 $2.63 Million
Q1 2020 May 15, 2020	BUY	$1.8 - $4.28 $628,993 - $1.5 Million	349,441 Added 214.42%	512,412 $999,000
Q4 2019 Feb 14, 2020	BUY	$3.16 - $5.15 $464,864 - $757,611	147,109 Added 927.43%	162,971 $676,000
Q3 2019 Nov 14, 2019	SELL	$1.2 - $6.66 $59,490 - $330,169	-49,575 Reduced 75.76%	15,862 $48,000
Q2 2019 Aug 14, 2019	SELL	$5.35 - $7.11 $913,159 - $1.21 Million	-170,684 Reduced 72.29%	65,437 $411,000
Q1 2019 May 15, 2019	SELL	$4.36 - $7.94 $141,067 - $256,898	-32,355 Reduced 12.05%	236,121 $1.31 Million
Q4 2018 Feb 14, 2019	BUY	$6.15 - $10.51 $1.06 Million - $1.82 Million	173,096 Added 181.48%	268,476 $1.78 Million
Q3 2018 Nov 14, 2018	BUY	$10.32 - $13.06 $183,118 - $231,736	17,744 Added 22.86%	95,380 $1.02 Million
Q2 2018 Aug 14, 2018	BUY	$7.8 - $13.69 $247,579 - $434,534	31,741 Added 69.16%	77,636 $932,000
Q1 2018 May 15, 2018	BUY	$7.86 - $11.39 $86,593 - $125,483	11,017 Added 31.59%	45,895 $393,000
Q4 2017 Feb 14, 2018	BUY	$8.77 - $12.28 $28,563 - $39,995	3,257 Added 10.3%	34,878 $345,000
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $384,827 - $515,422	31,621	31,621 $389,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $145M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account